Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-05

Clinical Trial Update: Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluated the effects of L-arginine supplementation in adults with moderate to severe asthma; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: University of California, Davis | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-06-05